Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Protein kinase C beta in malignant pleural mesothelioma.
[Locoregional therapy in hepatic metastases of colorectal cancer].
Role of cetuximab in the treatment of patients with NSCLC: are we throwing out the baby with the bath water?
Addressing the genetic/nongenetic duality in cancer with systems biology.
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer. Cancer Res. 2014 Feb 01; 74(3):884-95.
View in:
PubMed
subject areas
Amino Acid Sequence
Animals
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Cell Proliferation
Disease Models, Animal
Enzyme Activation
Female
Gene Expression
Gene Expression Regulation, Neoplastic
Gene Regulatory Networks
Humans
Indazoles
Lung Neoplasms
Mice
Niacinamide
Peptides
Proto-Oncogene Proteins c-met
Receptor Protein-Tyrosine Kinases
STAT3 Transcription Factor
Tumor Burden
Xenograft Model Antitumor Assays
authors with profiles
Everett Vokes
Ravi Salgia
Rifat Hasina
Aliya Husain